| Product Code: ETC6657901 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Haemophilia Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Haemophilia Market - Industry Life Cycle |
3.4 Canada Haemophilia Market - Porter's Five Forces |
3.5 Canada Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Canada Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Canada Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Canada Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 Canada Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Canada Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Canada Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about haemophilia and its treatment options in Canada |
4.2.2 Technological advancements in treatment options for haemophilia |
4.2.3 Rising prevalence of haemophilia in Canada due to genetic factors and improved diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with haemophilia treatment and medications |
4.3.2 Limited availability of specialized healthcare facilities and expertise for haemophilia care in certain regions of Canada |
5 Canada Haemophilia Market Trends |
6 Canada Haemophilia Market, By Types |
6.1 Canada Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Canada Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Canada Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 Canada Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 Canada Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 Canada Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 Canada Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 Canada Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Canada Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Canada Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Canada Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 Canada Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 Canada Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 Canada Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 Canada Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Canada Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 Canada Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 Canada Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Canada Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Canada Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Canada Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Canada Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Canada Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Canada Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Canada Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Haemophilia Market Import-Export Trade Statistics |
7.1 Canada Haemophilia Market Export to Major Countries |
7.2 Canada Haemophilia Market Imports from Major Countries |
8 Canada Haemophilia Market Key Performance Indicators |
8.1 Average time to diagnosis of haemophilia patients in Canada |
8.2 Number of clinical trials for new haemophilia treatments conducted in Canada |
8.3 Patient satisfaction with access to haemophilia treatment and care in different provinces |
9 Canada Haemophilia Market - Opportunity Assessment |
9.1 Canada Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Canada Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Canada Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Canada Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 Canada Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Canada Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Canada Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Haemophilia Market - Competitive Landscape |
10.1 Canada Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 Canada Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here